Subsequently, gain-of-function mutations of the LRP5 have been shown to be associated with disorders of increased bone mass, such as Van Buchem's disease, osteopetrosis, and endosteal hyperostosis [9-11]. This evidence concerns the gene LRP5 and hyperostosis corticalis generalisata.